Home Cart Sign in  
Chemical Structure| 178606-66-1 Chemical Structure| 178606-66-1

Structure of U-104
CAS No.: 178606-66-1

Chemical Structure| 178606-66-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

U-104 is a potent carbonic anhydrase (CA) inhibitor with Ki of 45.1 nM and 4.5 nM for CA IX and CA XII, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of U-104

CAS No. :178606-66-1
Formula : C13H12FN3O3S
M.W : 309.32
SMILES Code : NS(C1=CC=C(NC(NC2=CC=C(F)C=C2)=O)C=C1)(=O)=O
MDL No. :MFCD00159265
InChI Key :YJQZNWPYLCNRLP-UHFFFAOYSA-N
Pubchem ID :310360

Safety of U-104

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Description
U-104 (SLC-0111) is a highly potent inhibitor of carbonic anhydrase (CA) targeting CA IX and CA XII, with Ki values of 45.1 nM and 4.5 nM, respectively. U-104 exhibits notable efficacy in delaying tumor growth in mouse models[1][2].
Target
  • Carbonic Anhydrase IX

    CAIX, Ki:45.1 nM

  • Carbonic Anhydrase XII

    CAXII, Ki:4.5 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
4T1 murine breast cancer cells 100 µM 4-24 hours To evaluate the effect of U-104 on the viability of 4T1 cells, results showed that U-104 did not reduce cell viability at 100 µM concentration PMC7339283
Pt45.P1 cells 75 μM 48 hours To evaluate the contributions by CAIX to asTF-mediated tumor progression, results showed that U-104 had no significant effect on the proliferation and mobility of Pt45.P1 cells. PMC5121009
Pt45.P1/asTF+ cells 75 μM 48 hours To evaluate the contributions by CAIX to asTF-mediated tumor progression, results showed that U-104 significantly decreased the proliferation and mobility of Pt45.P1/asTF+ cells under hypoxic conditions. PMC5121009
MCF7 cells 50 μM Combination treatment with ASO targeting LINC02568 and CA12 inhibitor U-104 exhibited synergistic inhibitory effects on MCF7 cell proliferation and colony formation PMC10477896

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Orthotopic pancreatic tumor model Intraperitoneal injection 100 μl/dose Daily for four weeks To evaluate the inhibitory effect of U-104 on asTF-fueled tumor growth, results showed that U-104 significantly reduced the proliferation of tumor cells. PMC5121009
BALB/c-nu/nu male mice Mouse xenograft model of human-derived pancreatic ductal adenocarcinoma cell line MIAPaCa-2 Intraperitoneal injection 20 or 40 mg/kg Daily for 24 days To evaluate the effect of U-104 on tumor growth, results showed that 40 mg/kg dose of U-104 significantly delayed tumor growth PMC9979135
BALB/C nude mice MCF7 cell xenograft model Intraperitoneal injection 50 mg/kg Every other day for six times Combination treatment with ASO targeting LINC02568 and U-104 exhibited synergistic inhibitory effects on MCF7 cell-derived tumor growth PMC10477896

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.23mL

0.65mL

0.32mL

16.16mL

3.23mL

1.62mL

32.33mL

6.47mL

3.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories